Picture of Cellectis SA logo

ALCLS Cellectis SA Income Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual income statement for Cellectis SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
R2020
December 31st
R2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue21.42359.638.625.7
Cost of Revenue
Gross Profit-33.3-37.713.5-27.5-18.7
Selling / General / Administrative Expenses
Research And Development
Other Operating Expenses
Total Operating Expenses127147102142115
Operating Profit-105-124-42.3-103-89.7
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-88.3-115-53.6-96.8-98.6
Provision for Income Taxes
Net Income After Taxes-88.3-115-53.6-96.8-98.7
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-78.7-102-81.1-114-106
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-78.7-102-81.1-114-106
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1.93-2.41-0.875-1.92-1.99
Dividends per Share